Curaleaf maintains Aurora bid after rival Organigram proposal
Curaleaf said its enhanced October 6, 2026, offer for all outstanding Aurora Cannabis common shares remains outstanding despite Organigram Global’s alternative proposal.
1. Offer remains outstanding
Curaleaf said its enhanced October 6 offer for all outstanding Aurora Cannabis common shares remains outstanding. It said the bid offers better value, greater closing certainty and higher anticipated synergies, and criticized Aurora’s board for granting Organigram due diligence access while denying Curaleaf access, arguing this could prevent an enhanced bid.
